DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed): a randomised controlled trial of a structured group education programme for people newly diagnosed with type two diabetes
| ISRCTN | ISRCTN17844016 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17844016 |
| Protocol serial number | N/A |
| Sponsor | University Hospitals of Leicester NHS Trust (UK) |
| Funders | Diabetes UK (UK) (ref: BDA:RD04/0002922), Department of Health (UK), NovoNordisk (UK) - unrestricted educational grant |
- Submission date
- 19/04/2007
- Registration date
- 16/05/2007
- Last edited
- 30/07/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Melanie Davies
Scientific
Scientific
Leicester Diabetes Centre (Broadleaf)
Leicester General Hospital
Gwendolen Road
Leicester
LE5 4PW
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Cluster randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study acronym | DESMOND |
| Study objectives | To evaluate the effectiveness and feasibility of delivering structured group self-management education to individuals newly diagnosed with type two diabetes. |
| Ethics approval(s) | Approval received from Multi-centre Research Ethics Committee (MREC) on the 16th June 2004. |
| Health condition(s) or problem(s) studied | Self management of type two diabetes |
| Intervention | A programme of six hours of structured group education consisting of two three-hour sessions offered as either one day or two half-days, facilitated by two health care professionals trained to deliver the intervention to groups of up to ten people newly diagnosed with type two diabetes, who may be accompanied by a partner, family member or friend. This is compared to a control group receiving enhanced routine care. |
| Intervention type | Other |
| Primary outcome measure(s) |
Glycaemic control as measured by HbA1c at 12 months. |
| Key secondary outcome measure(s) |
1. Cardiovascular (CV) risk as measured by lipid profile and blood pressure |
| Completion date | 31/01/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Not Specified |
| Target sample size at registration | 1000 |
| Key inclusion criteria | 1. Greater than 18 years of age 2. Referred to the study within four weeks of diagnosis of type two diabetes 3. In intervention group, able to attend the intervention within 12 weeks of diagnosis |
| Key exclusion criteria | 1. Are unable to give informed consent 2. Have been recruited to take part, or are already taking part in other research 3. Have severe and enduring mental health problems 4. Are not primarily responsible for their own care 5. Are unable to participate in a group programme 6. Have insufficient understanding of English to participate in the group education |
| Date of first enrolment | 01/07/2004 |
| Date of final enrolment | 31/01/2007 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Leicester Diabetes Centre (Broadleaf)
Leicester
LE5 4PW
United Kingdom
LE5 4PW
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/03/2008 | Yes | No | |
| Results article | results | 26/04/2012 | Yes | No |